Turning scientific insights into strVtegic influence

The communications partner for companies whose science can change medicine.

01

Our Approach

Fluency changes what’s possible.

Scientific Insight

Clarity where others see complexity. Insight where others see noise.

Strategic Advisory

Strategy grounded in science. Led by those who have done it before.

Creative Storytelling

Science made clear. Stories made to matter.

Enduring Partnership

Present from day one. Invested in what comes next.

02

Our Experience

From ideas to medicines.

We support biopharma companies from launch to approval with corporate, scientific, and medical communications

02

Our Experience

From ideas to medicines.

The Full Arc of Biopharma.

Leveraging corporate, scientific, and medical communications to support companies across their journey.

orbital flow diagram

03

What We Do

Where strategy meets the page.

Corporate Communications

Messaging · Milestones · Financial · Crisis

Media Relations

Trade press · Mass media · Digital media

Thought Leadership

Speaking · Op-eds · Executive presence

Scientific & Medical Communications

Scientific platform · Publication & Congress strategy

Social & Digital Engagement

Web · Social · Owned channels

Creative & Branding

Identity · Design · Brand strategy

04

Who We Are

Scientists, strategists, and storytellers.

Open link
bio pic matt m web

Matt Middleman, M.D.

Founder, CEO
Open link
bio pic brittany l web

Brittany Leigh, Ph.D.

Co-Founder, EVP

Open link
bio pic jason b web

Jason Braco, Ph.D.

Co-Founder, EVP

Open link
bio pic dan p web

Dan Perlmutter

Co-Founder, EVP

05

Get In Touch

Let’s
connect.

Start A Conversation
button orbital icon
Let's Connect
Let's Connect
Let's Connect
Let's Connect
Scroll to Top
bio pic matt m web
Matt Middleman, M.D.
Founder, CEO

Matt is one of the most experienced leaders in healthcare communications, with a career that spans agency building, clinical medicine, scientific research, and Wall Street. He founded The Health & Science Agency to bring that depth to life sciences and pharmaceutical companies that demand more than traditional communications thinking.

He spent nearly a decade as founder and CEO of LifeSci Communications, building it from the ground up into a global firm that worked with hundreds of life sciences and pharmaceutical companies across every stage of development — having come up through the industry as a VP at Russo Partners, a leading boutique healthcare PR firm. Before communications, Matt spent 15 years as a physician and scientist, holding faculty positions at Albert Einstein College of Medicine and Montefiore Medical Center and conducting research in immunology and oncology at the NIH and Mount Sinai. Earlier, he worked as a biotechnology equities analyst, employing a contrarian investor’s approach to evaluating science and pipeline value.

Matt holds a B.S. in Biological Sciences from Cornell and an M.D. from the Icahn School of Medicine at Mount Sinai and has authored numerous peer-reviewed publications. Outside of work, he’s a husband and father of three — and the caretaker of a 12-animal household that keeps things interesting.

bio pic brittany l web
Brittany Leigh, Ph.D.
Co-Founder, EVP

Brittany is an Executive Vice President and Founding Partner at THSA who has spent her career making hard science understandable and impossible to ignore. She works closely with leadership teams across the drug development spectrum, from early-stage biotechs defining their scientific story to established pharma organizations managing the full complexity of mature R&D franchises.

Over the course of her career, Brittany has translated novel research into clear, credible narratives bridging corporate communications and medical and scientific communications as new therapies have moved from discovery toward the clinic. The executives she partners with get not just a strategist, but someone who understands their science as well as they do and can help them communicate it with confidence at every stage of the journey.

Prior to THSA, she spent five years at LifeSci Communications in positions of increasing responsibility. Brittany earned her Ph.D. in Biology from the University of South Florida and went on to complete postdoctoral work at Vanderbilt University in genetics and virology. When she’s not deep in the science, she can usually be found outside exploring with her husband, son and pup, rock climbing or buried in a new book.

bio pic jason b web
Jason Braco, Ph.D.
Co-Founder, EVP

Jason is a senior strategic communications advisor whose career sits at the intersection of rigorous science and high-stakes storytelling. He has counseled life sciences executives across every stage of development, helping companies working on some of the most novel approaches in medicine earn the visibility and credibility their science deserves.

Prior to THSA, she spent six years at LifeSci Communications in positions of increasing responsibility across account and media teams. Before his communications career, Jason spent nearly a decade as a research scientist, earning his Ph.D. in Biology from Wake Forest University and completing postdoctoral training at Yale School of Medicine, with a focus on genetics and cellular signaling. That scientific foundation shapes everything about how he works, giving him the fluency to craft narratives that resonate across every channel, from media relations to digital.

Jason thrives with leadership teams that want a genuine strategic partner, whether they are navigating their first major milestone or managing the complexity that comes with maturity. Outside of work, he can usually be found with his daughter and dog somewhere nearby and an audiobook playing in the background.

bio pic dan p web
Dan Perlmutter
Co-Founder, EVP

Dan Perlmutter is Executive Vice President and Founding Partner at THSA, where he leads business development efforts while also working closely with the account team behind the scenes to ensure all client programs are executed successfully. He brings over 15 years of experience in life sciences and financial services.

Most recently, he served as SVP of Business Development at LifeSci Communications for six-plus years, building a broad client portfolio ranging from companies coming out of stealth to those preparing for IPO, across pre-clinical to late-stage organizations. Prior to that, Dan spent eight and a half years at Bloomberg managing biotech and pharmaceutical client relationships with industry leaders including Celgene, Pfizer, Novartis, and Takeda. He holds a BA in English from the University of Massachusetts Amherst.

When not working, Dan enjoys traveling, with skiing at the top of the list – and spending time with his family, two daughters, and their two doodles.